MX9102612A - Derivados de trifluorometilcetona, procedimiento para la preparacion del mismo y uso del mismo. - Google Patents

Derivados de trifluorometilcetona, procedimiento para la preparacion del mismo y uso del mismo.

Info

Publication number
MX9102612A
MX9102612A MX9102612A MX9102612A MX9102612A MX 9102612 A MX9102612 A MX 9102612A MX 9102612 A MX9102612 A MX 9102612A MX 9102612 A MX9102612 A MX 9102612A MX 9102612 A MX9102612 A MX 9102612A
Authority
MX
Mexico
Prior art keywords
same
alkyl
preparation
derivatives
trifluorome
Prior art date
Application number
MX9102612A
Other languages
English (en)
Spanish (es)
Inventor
Keiji Hemmi
Ichiro Shima
Keisuke Imai
Hirokazu Tanaka
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909028231A external-priority patent/GB9028231D0/en
Priority claimed from GB919119713A external-priority patent/GB9119713D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of MX9102612A publication Critical patent/MX9102612A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Magnetically Actuated Valves (AREA)
  • Control Of Throttle Valves Provided In The Intake System Or In The Exhaust System (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Hydrogenated Pyridines (AREA)
MX9102612A 1990-12-31 1991-12-17 Derivados de trifluorometilcetona, procedimiento para la preparacion del mismo y uso del mismo. MX9102612A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909028231A GB9028231D0 (en) 1990-12-31 1990-12-31 Trifluoromethylketone derivatives,processes for preparation thereof and use thereof
GB919119713A GB9119713D0 (en) 1991-09-16 1991-09-16 Trifluoremethylketone derivatives, processes for preparation thereof and use thereof

Publications (1)

Publication Number Publication Date
MX9102612A true MX9102612A (es) 1992-06-01

Family

ID=26298196

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102612A MX9102612A (es) 1990-12-31 1991-12-17 Derivados de trifluorometilcetona, procedimiento para la preparacion del mismo y uso del mismo.

Country Status (19)

Country Link
US (2) US5296591A (cg-RX-API-DMAC7.html)
EP (1) EP0494071B1 (cg-RX-API-DMAC7.html)
JP (1) JPH0699378B2 (cg-RX-API-DMAC7.html)
KR (1) KR100192991B1 (cg-RX-API-DMAC7.html)
CN (1) CN1040003C (cg-RX-API-DMAC7.html)
AT (1) ATE151775T1 (cg-RX-API-DMAC7.html)
AU (1) AU641577B2 (cg-RX-API-DMAC7.html)
CA (1) CA2058560C (cg-RX-API-DMAC7.html)
DE (1) DE69218977T2 (cg-RX-API-DMAC7.html)
DK (1) DK0494071T3 (cg-RX-API-DMAC7.html)
ES (1) ES2099755T3 (cg-RX-API-DMAC7.html)
FI (1) FI106379B (cg-RX-API-DMAC7.html)
GR (1) GR3023719T3 (cg-RX-API-DMAC7.html)
HU (2) HU210263B (cg-RX-API-DMAC7.html)
IE (1) IE914360A1 (cg-RX-API-DMAC7.html)
MX (1) MX9102612A (cg-RX-API-DMAC7.html)
NO (1) NO309274B1 (cg-RX-API-DMAC7.html)
RU (1) RU2073684C1 (cg-RX-API-DMAC7.html)
SG (1) SG50457A1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296591A (en) * 1990-12-31 1994-03-22 Fujisawa Pharmaceutical Co., Ltd. Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
US5714470A (en) 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
US5478811A (en) * 1991-08-22 1995-12-26 Merrell Dow Pharmaceuticals Inc. Orally-active elastase inhibitors
FR2694295B1 (fr) * 1992-07-28 1994-09-02 Adir Nouveaux peptides dérivés de trifluoromethylcetones, leur procéde de préparation et les compositions pharmaceutiques qui les contiennent.
FR2719589B1 (fr) * 1994-05-05 1996-06-14 Adir Nouveaux peptides dérivés de trifluorométhylcétones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
MX9606034A (es) * 1994-06-02 1998-05-31 Merrell Pharma Inc Derivados enolicos acilados como profarmacos de inhibidores de elastasa.
JP3721538B2 (ja) * 1994-06-02 2005-11-30 メレル ファーマスーティカルズ インコーポレイテッド エラスターゼのパーフルオロアルキルケトン阻害剤およびそれらを製造する方法
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
JP2002161051A (ja) * 1996-12-24 2002-06-04 Fujisawa Pharmaceut Co Ltd 脳虚血性疾患等の治療剤
EP1057491B1 (en) * 1998-02-24 2013-06-19 Astellas Pharma Inc. Preventives/remedies for skin aging
US20020045231A1 (en) * 1999-02-02 2002-04-18 Napper Andrew D. Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies
EP1230933A4 (en) * 1999-10-12 2004-01-02 Fujisawa Pharmaceutical Co MEDICINE FOR NARROWED Wounds
IL148924A (en) * 2002-03-26 2015-06-30 Mor Research Applic Ltd Use of substances that inhibit intracellular elastase activity in the preparation of a drug for the treatment and / or prevention of necrosis of cells and related diseases
DE10219464A1 (de) 2002-04-30 2003-11-13 Focke & Co Zigarettenpackung
SE0202462D0 (sv) * 2002-08-14 2002-08-14 Astrazeneca Ab Novel use
AU2007267733B9 (en) * 2006-05-23 2011-04-21 Irm Llc Compounds and compositions as channel activating protease inhibitors
US20090202514A1 (en) * 2006-08-25 2009-08-13 Hiroyuki Yoneyama Agents for improving chronic obstructive pulmonary diseases
CA2669917A1 (en) * 2006-11-17 2008-05-22 Dawn M. George Aminopyrrolidines as chemokine receptor antagonists
PT2488486T (pt) * 2009-10-13 2019-11-05 Ligand Pharm Inc Compostos de moléculas pequenas de mimética de fator de crescimento hematopoiético e utilizações dos mesmos
ES2645847T3 (es) * 2013-05-08 2017-12-11 Kissei Pharmaceutical Co., Ltd. Derivado de glicinamida alfa-sustituido
CN104650016A (zh) * 2015-01-29 2015-05-27 武汉大学 拟三肽类化合物及其制备方法
BR112018073968B1 (pt) * 2016-06-24 2022-08-02 Pola Chemical Industries, Inc Preparação tópica para melhoria de rugas na pele
EP3711746A4 (en) 2017-11-15 2021-08-25 Pola Chemical Industries Inc. OIL-BASED COMPOSITION
CN119241385B (zh) * 2024-11-29 2025-03-25 江西师范大学 β-酰氧基烯酰胺衍生物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
EP0276101A3 (en) * 1987-01-19 1989-11-23 Ici Americas Inc. Substituted peptide derivatives
EP0369391A3 (en) 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituted amides
US5221665A (en) * 1989-10-27 1993-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. N-substituted amides
US5296591A (en) * 1990-12-31 1994-03-22 Fujisawa Pharmaceutical Co., Ltd. Trifluoromethylketone derivatives, processes for preparation thereof and use thereof

Also Published As

Publication number Publication date
NO920035L (no) 1992-07-01
JPH04297446A (ja) 1992-10-21
KR100192991B1 (ko) 1999-06-15
CA2058560C (en) 2000-12-12
FI106379B (fi) 2001-01-31
GR3023719T3 (en) 1997-09-30
US5430025A (en) 1995-07-04
DE69218977D1 (de) 1997-05-22
EP0494071A2 (en) 1992-07-08
KR920011988A (ko) 1992-07-25
DE69218977T2 (de) 1997-08-07
AU8985391A (en) 1992-07-02
HU211943A9 (en) 1996-01-29
NO920035D0 (no) 1992-01-02
IE914360A1 (en) 1992-07-01
CA2058560A1 (en) 1992-07-01
NO309274B1 (no) 2001-01-08
ES2099755T3 (es) 1997-06-01
FI915996A0 (fi) 1991-12-19
CN1040003C (zh) 1998-09-30
SG50457A1 (en) 1998-07-20
JPH0699378B2 (ja) 1994-12-07
RU2073684C1 (ru) 1997-02-20
EP0494071A3 (en) 1993-05-05
FI915996L (fi) 1992-07-01
US5296591A (en) 1994-03-22
AU641577B2 (en) 1993-09-23
HU210263B (en) 1995-03-28
ATE151775T1 (de) 1997-05-15
HU914153D0 (en) 1992-03-30
DK0494071T3 (cg-RX-API-DMAC7.html) 1997-05-12
CN1063108A (zh) 1992-07-29
EP0494071B1 (en) 1997-04-16
HUT60507A (en) 1992-09-28

Similar Documents

Publication Publication Date Title
MX9102612A (es) Derivados de trifluorometilcetona, procedimiento para la preparacion del mismo y uso del mismo.
ATE185792T1 (de) Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen
ATE161836T1 (de) 4-substituierte-2-deoxy-2,3-didehydro alpha-d- neuraminsäure antivirale derivate
DK245888A (da) 4-aminoquinolinderivater
NO900306L (no) Fremgangsmaate for fremstilling av nye pyrazolopyridin-forbindelser.
DK0889876T3 (da) Meta-substituerede phenylensulfonamidderivater
NO921835L (no) Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav
DE69624437D1 (de) 4,6-diarylpyrimidin-derivate und deren salze
BR9713884A (pt) Benzamida heterociclicamente substituìda, usos da mesma e de cetobenzamidoaldeìdos desta, e, preparação medicamentosa.
DE59010536D1 (de) Diphenylheteroalkylderivate, ihre Herstellung und daraus hergestellte Arzneimittel und Kosmetika
ES2091359T3 (es) Nuevo compuesto peptidico y un procedimiento para su preparacion.
IL106445A0 (en) 4-substituted 1,2,4-triazole derivatives,their preparation and pharmaceutical compositions containing them
ES2117013T3 (es) Derivado de difenilpiperazina y medicamento para organos del aparato circulatorio que contiene este compuesto.
DK0625516T3 (da) Benzensulfonamidderivater til behandling af blæreustabilitet
FI935800A0 (fi) Antidepressiva och mot Parkisons sjukdom verksamma foereningar
DE59006868D1 (de) 2-Alkyl-4-arylmethylaminochinoline, ihre Verwendung und daraus hergestellte Arzneimittel.
DE69330601D1 (de) Serotoninergische ergolin derivate
NO950177D0 (no) Farmakologisk aktive erivater
NO923983L (no) Bisfenyletanderivater, fremgangsmaate for deres fremstilling og farmasoeytiske preparater derav
ITMI911445A0 (it) Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva
DE69829849D1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
HUP0003555A2 (hu) Gombaellenes hatású triazolszármazékok, ezeket tartalmazó gyógyszerkészítmények és intermedierjük
SE8903313L (sv) Nya 2-metoxikarbonyl-substituerade n,n'-di-(trimetoxibensoyl)-piperaziner, foerfarande foer framstaellning daerav och terapeutiska foereningar innehaallande dem
DE3169918D1 (en) Cis-c3",c4"-carbonate derivatives of oleandomycin-y, pharmaceutical compositions containing them, and intermediates therefor